Artigo
Revisado por pares
Rituximab prolongs the time to relapse in patients with immune thrombotic thrombocytopenic purpura: analysis of off-label use in Japan
2020; Springer Science+Business Media; Volume: 112; Issue: 6 Linguagem: Inglês
10.1007/s12185-020-02974-y
ISSN1865-3774
AutoresMasayuki Kubo, Kazuya Sakai, Yumi Yoshii, Masaki Hayakawa, Masanori Matsumoto,
Tópico(s)Platelet Disorders and Treatments
Referência(s)